Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha4 integrins

Details for Australian Patent Application No. 2003237302 (hide)

International Classifications

Event Publications

11 September 2003 Complete Application Filed

Priority application(s): 60/383,244 24.05.02 US

5 February 2004 Application Open to Public Inspection

Published as AU-B-2003237302

6 March 2008 Application Accepted

Published as AU-B-2003237302

3 April 2008 Corrigenda

Applications Accepted - Name Index Under the name Elan Pharmaceuticals, Inc., Application No. 2003237302, under INID (72), correct co-inventor names to read Semko, Christopher M. and Thorsett, Eugene D.

3 July 2008 Standard Patent Sealed

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.